Promising New Treatment Rates High for Bladder Cancer

According to the Urology Care Foundation, bladder cancer is the sixth most common cancer in the United States. In 2014, an estimated 15,000 individuals will die from this devastating disease.

 Vice President of Oncology at Merck Research Lab, Dr. Alise Reicin, encouragingly spoke out in a recent statement, “Although at this stage the dataset is small, we are encouraged by the response rate, complete response rate, and the durability of the response in patients suffering from advanced bladder cancer.” She continued, “As communicated previously, based on these data Merck will initiate a Phase 3 study this year to better understand the potential of KEYTRUDA in advanced bladder cancer.”

Read More...  Promising New Treatment Rates High for Bladder Cancer